After his undergraduate in biochemistry at the Georgia Institute of Technology, Dr. Sodji enrolled in the University System of Georgia MD/PhD program where he completed his Ph.D in medicinal chemistry at the Georgia Institute of Technology and M.D at the Medical College of Georgia. He subsequently completed his residency in Radiation Oncology at Stanford University where he pursued the ABR Holman Research Pathway in the laboratory of Dr. Amato Giaccia, studying the impact of the complement system on the recruitment and cytotoxic activity of natural killer cells in the tumor microenvironment.
Faculty
Autumn Walter-Denzin, PhD, DABR
Jennie Crosby, PhD
My clinical work focuses on adaptive and MR-guided radiotherapy through my work with the ViewRay MRIdian system. This system gives us the opportunity, via MR imaging, to adapt the patient’s radiation plan to their anatomy on the day of treatment and enables us to visualize the anatomy throughout treatment. In addition to my clinical work on the ViewRay system, I have a strong interest in increasing automation throughout the clinic to streamline workflows. My research has primarily focused on patient safety and quality management, including analysis of trends and investigation of workflow inefficiencies.
Jordan Slagowski, PhD, DABR
I am an assistant professor and board-certified medical physicist in the Department of Human Oncology at the University of Wisconsin – Madison. My clinical sub-specialty is brachytherapy. I also provide general physics support across the Department.
Colin Harari, MD
Lindsay Zammit, PhD
I am a clinical medical physicist and Assistant Professor in the Department of Human Oncology. I provide clinical services at the UW and the William S. Middleton Memorial Veterans Hospital.
Gemma Davies, PhD, DABR
I am a medical physicist board-certified in radiation oncology in both the U.K., where I did my initial training, and the U.S. My primary focus is ensuring that patient treatments are executed correctly and safely through comprehensive review of radiation treatment plans and quality assurance of the treatment machines used to deliver radiation. I am also focused on providing physics support for clinical trial execution and data management within the Department of Human Oncology.
Shuang (George) Zhao, MD
The Zhao Lab focuses on developing novel clinical biomarkers that predict response and resistance to specific therapies across cancers. These biomarkers can be used to better select which patients derive a benefit from treatment, which patients do not and can be spared potential toxicity, as well as monitor for emergence of resistance. It seeks to use advanced computational approaches and liquid biopsy technologies to better personalize the care of cancer patients.
Carri Glide-Hurst, PhD, DABR, FAAPM
Carri Glide-Hurst, PhD, DABR, FAAPM is a tenured Professor in the Department of Human Oncology and member of the UW Carbone Cancer Center. She serves as the Director of Radiation Oncology Physics and Bhudatt Paliwal Endowed Professor at the University of Wisconsin. Dr. Glide-Hurst obtained a PhD in Medical Physics from Wayne State University with an emphasis on evaluating breast density, a known risk factor for breast cancer, using ultrasound tomography.